Your NEJM Group Today: Limb Weakness Case / Cannabis & Depression / California Family Medicine Opportunities — Physician’s First Watch

Medical News |
September 13, 2017

Your NEJM Group Today: Limb Weakness Case / Cannabis & Depression / California Family Medicine Opportunities

By the Editors

Take a look at today's offering from NEJM Group:

NEJM Clinical Practice Center: Clinical Problem-Solving: A 46-year-old woman presented to the emergency department with limb weakness. In the preceding 3 months, back pain, hip flexor weakness, and numbness of a finger had developed, followed by weakness and shooting pains in her limbs and weakness in facial muscles. See an expert clinician's take on the case at the link below.

NEJM Journal Watch Psychiatry: Cannabis use may be causally associated with depression and suicidal ideation.

NEJM CareerCenter: Adventist Health Lodi Memorial is seeking family medicine physicians to treat patients in a rural community less than an hour from Sacramento, California.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.